We are live on ! Find out more
PTC

Philadelphia Trust Company Portfolio holdings

AUM $1.42B
1-Year Est. Return 43.77%
This Fund
S&P 500
This Quarter Est. Return
+5.78%
1 Year Est. Return
+43.77%
3 Year Est. Return
+141.5%
5 Year Est. Return
+176.17%
10 Year Est. Return
+554.31%
AUM
$1.22B
AUM Growth
+$40.9M
Cap. Flow
-$16.8M
Cap. Flow %
-1.38%
Top 10 Hldgs %
28.46%
Holding
227
New
18
Increased
72
Reduced
83
Closed
22

Top Buys

Rank Stock Value
1
DD icon
DuPont de Nemours
DD
+$28.2M
2
CELG
Celgene Corp
CELG
+$14.3M
3
C icon
Citigroup
C
+$11.5M
4
VVV icon
Valvoline
VVV
+$8.37M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$8.12M

Sector Composition

Rank Sector Weight
1 Technology 21.86%
2 Financials 18.83%
3 Healthcare 15.34%
4 Communication Services 11.28%
5 Industrials 8.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BRK.B icon
1
Berkshire Hathaway Class B
BRK.B
$1.07T
$39.9M 3.28%
217,849
+6,572
+3% +$1.16M
ABT icon
2
Abbott
ABT
$182B
$37.9M 3.12%
710,926
-1,358
-0.2% -$68.1K
MSFT icon
3
Microsoft
MSFT
$2.89T
$36.9M 3.03%
495,259
+14,559
+3% +$1.06M
AAPL icon
4
Apple
AAPL
$4.95T
$35.7M 2.93%
927,256
-132,216
-12% -$5.13M
PG icon
5
Procter & Gamble
PG
$346B
$35.1M 2.89%
386,212
+41,195
+12% +$3.75M
GOOGL icon
6
Alphabet (Google) Class A
GOOGL
$3.99T
$34.5M 2.83%
708,440
-40,180
-5% -$1.91M
LLL
7
DELISTED
L3 Technologies, Inc.
LLL
$34.2M 2.81%
181,684
-3,237
-2% -$581K
BIIB icon
8
Biogen
BIIB
$29.5B
$31.5M 2.59%
100,588
+5,308
+6% +$1.57M
C icon
9
Citigroup
C
$223B
$30.6M 2.52%
421,121
+168,857
+67% +$11.5M
DD icon
10
DuPont de Nemours
DD
$18.9B
$30M 2.47%
171,369
+168,783
+6,527% +$28.2M
VZ icon
11
Verizon
VZ
$198B
$29.6M 2.43%
597,558
+270
+0% +$12.7K
META icon
12
Meta Platforms (Facebook)
META
$1.51T
$28.4M 2.33%
166,219
+10,322
+7% +$1.72M
RTN
13
DELISTED
Raytheon Company
RTN
$25.6M 2.1%
136,937
+5,309
+4% +$935K
BAC icon
14
Bank of America
BAC
$436B
$24.9M 2.04%
981,914
+96,714
+11% +$2.35M
MCHP icon
15
Microchip Technology
MCHP
$42.3B
$24.4M 2%
542,726
-4,610
-0.8% -$193K
ABB
16
DELISTED
ABB Ltd
ABB
$23.8M 1.95%
961,005
+123,335
+15% +$2.95M
CIT
17
DELISTED
CIT Group Inc.
CIT
$23.6M 1.94%
481,066
-107,845
-18% -$5.07M
NXPI icon
18
NXP Semiconductors
NXPI
$67.6B
$22.2M 1.83%
196,605
-2,570
-1% -$287K
CELG
19
DELISTED
Celgene Corp
CELG
$21.8M 1.79%
149,711
+104,755
+233% +$14.3M
CVS icon
20
CVS Health
CVS
$137B
$21.1M 1.73%
259,385
-64,249
-20% -$5.08M
VVV icon
21
Valvoline
VVV
$5.05B
$18.5M 1.52%
788,145
+372,980
+90% +$8.37M
AMGN icon
22
Amgen
AMGN
$203B
$17.4M 1.43%
93,577
-1,240
-1% -$220K
GS icon
23
Goldman Sachs
GS
$309B
$17.3M 1.42%
73,039
+2,602
+4% +$587K
TWX
24
DELISTED
Time Warner Inc
TWX
$17.1M 1.4%
166,561
-4,125
-2% -$418K
NVDA icon
25
NVIDIA
NVDA
$4.76T
$16.9M 1.39%
3,774,360
-722,400
-16% -$3M

Similar funds

Philadelphia Trust Company's Q3 2017 Portfolio in Review

As of Q3 2017, Philadelphia Trust Company held 227 positions worth $1.22B, up 3.5% from $1.18B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Philadelphia Trust Company's Q3 2017 filing shows 18 new, 72 increased, 83 reduced and 22 closed positions. Its largest new stake was Hewlett Packard: 552,115 shares worth $8.12M. The largest sale was Du Pont De Nemours E I, an estimated $27.2M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 22% a quarter earlier, followed by Financials and Healthcare.

  • Philadelphia Trust Company's largest Q3 2017 buy was Hewlett Packard: 552,115 shares worth $8.12M.
  • Philadelphia Trust Company added most to DuPont de Nemours in Q3 2017, an estimated $28.2M increase.
  • Philadelphia Trust Company's biggest Q3 2017 reduction was American Express, cutting an estimated $11.7M.
  • Philadelphia Trust Company fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $27.2M.
  • Philadelphia Trust Company's ten largest holdings make up 28% of its $1.22B portfolio in Q3 2017.
  • Philadelphia Trust Company opened 18 new positions and closed 22 in Q3 2017.
  • Philadelphia Trust Company's portfolio value rose 3.5% quarter-over-quarter to $1.22B.

Based on Philadelphia Trust Company's 13F filing for Q3 2017, filed 13 Nov 2017.